Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Market watchers are expecting strong growth driven by the https://violagdxr777745.jts-blog.com/35781159/eli-lilly-stock-a-deep-dive-into-q3-earnings